These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35911648)

  • 1. Synergistic anticancer mechanisms of curcumol and paclitaxel in triple-negative breast cancer treatment may involve down-regulating ZBTB7A expression via the NF-B signaling pathway.
    Mao A; Qin Q; Yang W; Wei C
    Iran J Basic Med Sci; 2022 May; 25(5):652-658. PubMed ID: 35911648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer.
    Chen J; Deng S; Zhang Y; Wang C; Hu X; Kong D; Liang G; Yuan X; Li Y; Wang X
    Ann Transl Med; 2021 Jun; 9(12):1001. PubMed ID: 34277801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumol triggers apoptosis of p53 mutant triple-negative human breast cancer MDA-MB 231 cells via activation of p73 and PUMA.
    Huang L; Li A; Liao G; Yang F; Yang J; Chen X; Jiang X
    Oncol Lett; 2017 Jul; 14(1):1080-1088. PubMed ID: 28693277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumol enhances the anti-tumor effects of metformin via suppressing epithelial-mesenchymal transition in triple-negative breast cancer.
    Wang G; Dong Y; Liu H
    Ann Transl Med; 2020 Aug; 8(15):946. PubMed ID: 32953746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
    Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
    J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Effect of Graphene Oxide Coated Nanotised Apigenin with Paclitaxel (GO-NA/PTX): A ROS Dependent Mitochondrial Mediated Apoptosis in Ovarian Cancer.
    Pal MK; Jaiswar SP; Dwivedi A; Goyal S; Dwivedi VN; Pathak AK; Kumar V; Sankhwar PL; Ray RS
    Anticancer Agents Med Chem; 2017; 17(12):1721-1732. PubMed ID: 28443516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways.
    Wang P; Song D; Wan D; Li L; Mei W; Li X; Han L; Zhu X; Yang L; Cai Y; Zhang R
    PeerJ; 2020; 8():e9281. PubMed ID: 32547883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
    Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
    Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumol Suppresses Breast Cancer Cell Metastasis by Inhibiting MMP-9 Via JNK1/2 and Akt-Dependent NF-κB Signaling Pathways.
    Ning L; Ma H; Jiang Z; Chen L; Li L; Chen Q; Qi H
    Integr Cancer Ther; 2016 Jun; 15(2):216-25. PubMed ID: 27125675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt/β-catenin signaling.
    Gao J; Hou D; Hu P; Mao G
    Transl Cancer Res; 2021 May; 10(5):2437-2450. PubMed ID: 35116559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-153-5p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Paclitaxel by Inducing G2M Phase Arrest.
    Wang Y; Wu N; Zhang J; Wang H; Men X
    Onco Targets Ther; 2020; 13():4089-4097. PubMed ID: 32494162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin Inhibits Proliferation and Induces Apoptosis in Breast Cancer by Down-Regulating FBI-1-Mediated NF-κB Pathway.
    Chen M; Xiao C; Jiang W; Yang W; Qin Q; Tan Q; Lian B; Liang Z; Wei C
    Drug Des Devel Ther; 2021; 15():125-140. PubMed ID: 33469265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZBTB7A promotes migration, invasion and metastasis of human breast cancer cells through NF-κB-induced epithelial-mesenchymal transition in vitro and in vivo.
    Mao A; Chen M; Qin Q; Liang Z; Jiang W; Yang W; Wei C
    J Biochem; 2019 Dec; 166(6):485-493. PubMed ID: 31385585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational and in vitro analyses on synergistic effects of paclitaxel and thymoquinone in suppressing invasive breast cancer cells.
    Khazaei MR; Bozorgi M; Khazaei M; Moradi A; Bozorgi A
    Mol Biol Rep; 2024 Mar; 51(1):388. PubMed ID: 38446390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer.
    Speyer CL; Bukhsh MA; Jafry WS; Sexton RE; Bandyopadhyay S; Gorski DH
    Breast Cancer Res Treat; 2017 Nov; 166(2):407-419. PubMed ID: 28780701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines.
    Harada K; Ferdous T; Kobayashi H; Ueyama Y
    Int J Oncol; 2014 Dec; 45(6):2439-45. PubMed ID: 25230791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line.
    Kumari S; Mohan MG; Shailender G; Badana AK; Malla RR
    J Cell Biochem; 2019 Oct; 120(10):18104-18116. PubMed ID: 31172606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
    Chougule MB; Patel AR; Jackson T; Singh M
    PLoS One; 2011 Mar; 6(3):e17733. PubMed ID: 21423660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.